Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bioBob
    Member
    • Mar 2011
    • 72

    issues with SOAPdenovo

    Hello.
    I am wondering if anyone here some some experience with SOAPdenovo.

    I am trying to assembly Illumina data, I have 3 lanes of 101 cycle PE data and 2 lanes of single read data.

    I have tried all sorts of options for running the program down to the default ./SOAPdenovo63mer all -s SOAPdenovo_config.txt -o out_

    At the end of the day (ok, only 2 hours), it is telling me 'no paired reads found' and tossed a terminal error.

    I have used this same data in both CLC and Velvet and it works fine including scaffolding in Velvet and paired mapping in CLC.

    I am sure I am doing something silly. Any thoughts?

    Thanks,
    Bob

    ps. my config file is:

    #maximal read length
    max_rd_len=100
    [LIB]
    #average insert size
    avg_ins=200
    #if sequence needs to be reversed
    reverse_seq=0
    #in which part(s) the reads are used
    asm_flags=1
    #in which order the reads are used while scaffolding
    rank=1
    p=/common/groups/Illx/Genomic_SIPES_lane5_1_paired_trimmed_paired.fastq
    p=/common/groups/Illx/Genomic_SIPES_lane6_1_paired_trimmed_paired.fastq
    p=/common/groups/Illx/Genomic_SIPES_lane7_1_paired_trimmed_paired.fastq
    q=/common/groups/Illx/Unpaired_SIPES_PF_lane5_1_trimmed.fastq
    q=/common/groups/Illx/Unpaired_SIPES_PF_lane7_1_trimmed.fastq
  • jvhaarst
    Member
    • Sep 2008
    • 14

    #2
    It has been a while since I looked at SOAPdenovo, but could you try this config ?
    ----
    #maximal read length
    max_rd_len=100
    [LIB]
    #average insert size
    avg_ins=200
    #if sequence needs to be reversed
    reverse_seq=0
    #in which part(s) the reads are used
    asm_flags=1
    #in which order the reads are used while scaffolding
    rank=1
    q=/common/groups/Illx/Unpaired_SIPES_PF_lane5_1_trimmed.fastq
    q1=/common/groups/Illx/Unpaired_SIPES_PF_lane7_1_trimmed.fastq

    [LIB]
    #average insert size
    avg_ins=200
    #if sequence needs to be reversed
    reverse_seq=0
    #in which part(s) the reads are used
    asm_flags=3
    #in which order the reads are used while scaffolding
    rank=2
    q=/common/groups/Illx/Genomic_SIPES_lane5_1_paired_trimmed_paired.fastq
    q1=/common/groups/Illx/Genomic_SIPES_lane6_1_paired_trimmed_paired.fastq
    q2=/common/groups/Illx/Genomic_SIPES_lane7_1_paired_trimmed_paired.fastq

    Comment

    • bioBob
      Member
      • Mar 2011
      • 72

      #3
      Thanks.

      Unfortunately, it appears as though it was a case of RTFM more carefully. Paired reads have to be in fast-a format if in a single file. I only wasted 2 days because I didn't see that earlier. =/

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Yesterday, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:10 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...